 LEXINGTON, Mass., Aug. 04, 2021 GLOBE NEWSWIRE -- T2 Biosystems, Inc. NASDAQ:TTOO, a leader in the rapid detection of sepsis-causing pathogens, today announced plans to participate in the upcoming Canaccord Genuity 41st Annual Growth Conference. 